JB/CALL/ROCHE GS/325/0.02/21.06.24 Share Price

Warrant

ROGEJB

CH1225606198

Market Closed - Swiss Exchange 16:20:00 15/05/2024 BST
0.002 CHF -33.33% Intraday chart for JB/CALL/ROCHE GS/325/0.02/21.06.24
3 months-81.82%
6 months-90.00%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Bank Julius Bär
ROGEJB
ISINCH1225606198
Date issued 04/01/2023
Strike 325 CHF
Maturity 21/06/2024 (13 Days)
Parity 50 : 1
Emission price 0.23 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 0.24 CHF
Lowest since issue 0.001 CHF
Spread 0.002 CHF
Spread %66.67%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
242.6 CHF
Average target price
277.5 CHF
Spread / Average Target
+14.40%
Consensus
  1. Stock Market
  2. Warrants
  3. ROGEJB Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW